We are live on
!
Find out more
LP
LMR Partners Portfolio holdings
AUM
$45.4B
1-Year Est. Return
60.68%
This Fund
S&P 500
This Quarter
Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
(+31%)
Cap. Flow
+$324M
Cap. Flow
% of AUM
2.32%
Top 10 Holdings %
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$176M |
| 2 |
Infosys
INFY
|
+$102M |
| 3 |
K
Kellanova
K
|
+$74.6M |
| 4 |
Amazon
AMZN
|
+$58.6M |
| 5 |
Alibaba
BABA
|
+$52.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$114M |
| 2 |
HDFC Bank
HDB
|
+$97.7M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$55.3M |
| 4 |
Roper Technologies
ROP
|
+$45.7M |
| 5 |
Nutanix
NTNX
|
+$44.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.38% |
| 2 | Financials | 4.13% |
| 3 | Consumer Discretionary | 2.33% |
| 4 | Communication Services | 2.26% |
| 5 | Healthcare | 2.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
PUT
Apollo Global Management
APO
$70.7B
| $454K | ﹤0.01% |
+3,200
| New | +$424K |
|
927
CALL
Boston Scientific
BSX
$65.8B
| $451K | ﹤0.01% |
+4,200
| New | +$425K |
|
|
928
PUT
Boston Scientific
BSX
$65.8B
| $451K | ﹤0.01% |
+4,200
| New | +$425K |
|
929
Clorox
CLX
$11.6B
| $447K | ﹤0.01% |
3,726
-3,615
| -49% | -$482K |
|
930
CALL
Electronic Arts
EA
$52.4B
| $447K | ﹤0.01% |
2,800
-16,600
| -86% | -$2.45M |
|
931
CALL
AbbVie
ABBV
$458B
| $445K | ﹤0.01% |
2,400
-17,900
| -88% | -$3.33M |
|
932
PUT
McKesson
MCK
$98.5B
| $440K | ﹤0.01% |
600
-300
| -33% | -$212K |
|
|
B
933
CALL
Barrick Mining
B
$62.2B
| $437K | ﹤0.01% |
+21,000
| New | +$410K |
|
934
CALL
Abbott
ABT
$180B
| $435K | ﹤0.01% |
+3,200
| New | +$422K |
|
|
935
PUT
Abbott
ABT
$180B
| $435K | ﹤0.01% |
+3,200
| New | +$422K |
|
|
MVSTW
936
DELISTED
Microvast Holdings Warrants
MVSTW
| $434K | ﹤0.01% |
1,181,416
| – | – |
|
|
TBLAW
937
DELISTED
Taboola.com Ltd Warrant
TBLAW
| $431K | ﹤0.01% |
1,796,134
| – | – |
|
938
CALL
PNC Financial Services
PNC
$100B
| $429K | ﹤0.01% |
+2,300
| New | +$389K |
|
|
RNWWW
939
ReNew Energy Global PLC Warrant
RNWWW
$59.3K
| $425K | ﹤0.01% |
3,145,717
| – | – |
|
940
Eaton
ETN
$157B
| $422K | ﹤0.01% |
1,183
+1,181
| +59,050% | +$364K |
|
941
Cintas
CTAS
$82.4B
| $422K | ﹤0.01% |
+1,894
| New | +$408K |
|
942
Fastenal
FAST
$54B
| $421K | ﹤0.01% |
10,020
+4,342
| +76% | +$176K |
|
943
CALL
Yum! Brands
YUM
$41B
| $415K | ﹤0.01% |
+2,800
| New | +$409K |
|
944
PUT
ConocoPhillips
COP
$147B
| $413K | ﹤0.01% |
4,600
+1,100
| +31% | +$99K |
|
945
CALL
FirstEnergy
FE
$28.9B
| $411K | ﹤0.01% |
+10,200
| New | +$421K |
|
946
Labcorp
LH
$24.3B
| $407K | ﹤0.01% |
1,552
+613
| +65% | +$149K |
|
947
Lear
LEA
$7.19B
| $405K | ﹤0.01% |
4,267
-33
| -0.8% | -$2.9K |
|
|
DMYY.WS
948
DELISTED
dMY Squared Technology Group Warrants
DMYY.WS
| $404K | ﹤0.01% |
211,665
+95,826
| +83% | +$146K |
|
949
CALL
Allstate
ALL
$66.9B
| $403K | ﹤0.01% |
+2,000
| New | +$399K |
|
|
950
PUT
Allstate
ALL
$66.9B
| $403K | ﹤0.01% |
+2,000
| New | +$399K |
|
Similar funds
AS
TI
LMR Partners's Q2 2025 Portfolio in Review
As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.
By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
- LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
- LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
- LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
- LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
- LMR Partners opened 418 new positions and closed 391 in Q2 2025.
- LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.
Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.